Detalles de la búsqueda
1.
Personalized treatment is better than one treatment fits all in the management of patients with mCRC: a consensus statement.
Future Oncol
; 10(16): 2643-57, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25531050
2.
Resource Oriented Decision Making for Treatment of Metastatic Colorectal Cancer (mCRC) in a Lower-Middle Income Country: Egyptian Foundation of Medical Sciences (EFMS) Consensus Recommendations 2020.
Cancer Manag Res
; 14: 821-842, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35250310
3.
A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer.
Int J Clin Oncol
; 15(4): 382-9, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20354750
4.
Adjuvant chemotherapy for luminal A breast cancer: a prospective study comparing two popular chemotherapy regimens.
Onco Targets Ther
; 6: 1073-7, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23966793
5.
Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel and cisplatin/pemetrexed in chemotherapy-naïve patients with advanced non-squamous bronchogenic carcinoma not harboring EGFR mutation.
Onco Targets Ther
; 6: 803-9, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23836994
6.
Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel versus carboplatin/docetaxel in initial treatment of metastatic Her-2-negative breast cancer.
Breast Cancer (Dove Med Press)
; 5: 37-42, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24648756
Resultados
1 -
6
de 6
1
Próxima >
>>